[1]任静芸,杨吉刚.18F-L-DOPA PET/CT显像诊断先天性高胰岛素血症的研究进展[J].国际放射医学核医学杂志,2015,39(1):67-70.[doi:10.3760/cma.j.issn.1673-4114.2015.01.014]
　Ren Jingyun,Yang Jigang.Research progress of 18F-L-DOPA PET/CT in the diagnosis of congenital hyperinsulinism[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):67-70.[doi:10.3760/cma.j.issn.1673-4114.2015.01.014]
点击复制

18F-L-DOPA PET/CT显像诊断先天性高胰岛素血症的研究进展(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
39
期数:
2015年第1期
页码:
67-70
栏目:
出版日期:
2015-01-25

文章信息/Info

Title:
Research progress of 18F-L-DOPA PET/CT in the diagnosis of congenital hyperinsulinism
作者:
任静芸;  杨吉刚
首都医科大学附属北京友谊医院核医学科, 北京, 100050
Author(s):
Ren Jingyun;  Yang Jigang
Department of Nuclear Medicine, Beijing Friendship Hospital Affiliated to Capital Medical University, Beijing 100050, China
关键词:
先天性高胰岛素血症; 左旋多巴; 正电子发射断层扫描术; 体层摄影术; X线计算机
Keywords:
Congenital hyperinsulinism; Levodopa; Positron-emission tomography; Tomography;  X-ray computed
DOI:
10.3760/cma.j.issn.1673-4114.2015.01.014
摘要:
先天性高胰岛素血症(CHI)是由于胰腺β细胞分泌过多的胰岛素导致顽固性的低血糖及与血糖水平不相称的相对高胰岛素血症。CHI的治疗方法包括内科治疗和外科手术治疗,对于内科治疗无效或效果不佳的患者常需要外科手术治疗。CHI主要分为局灶型和弥漫型,局灶型CHI可通过外科手术切除病灶而治愈,弥漫型CHI需进行胰腺次全切除术治疗。因此,手术治疗前明确病理类型至关重要。CT、MRI及超声等影像学检查对于鉴别局灶型与弥漫型CHI具有一定的局限性,而18F-左旋多巴PET/CT显像具有一定优势。笔者对18F-左旋多巴PET/CT显像诊断CHI进行了综述,对临床实践具有一定的指导意义。
Abstract:
Congenital hyperinsulinism (CHI) is a condition leading to recurrent hypoglycemia due to an inappropriate insulin secretion by the pancreatic islet β cells. There are two main histologic subtypes: diffuse and focal, which may require different treatment strategies. Patients with diffuse CHI disease require a neartotal pancreatectomy. However patients with focal CHI disease only require a limited pancreatectomy to remove only the focal lesion thus providing complete cure to the patient. Hence the preoperative diagnosis of the histological subtypes of CHI becomes paramountin during the management of CHI. There was no advantages of morphological imaging methods, such as CT and MRI, in the differential diagnosis of focal and diffuse CHI. The CHI patient should perform 18Fluoride-L-dihydroxyphenylalanine(18F-L-DOPA) PET scan to differentiate focal from diffuse lesion, which can provide guidance for operation.This paper reviewed the research progress of 18F-L-DOPA PET scan in the diagnosis of CHI in recent years.

参考文献/References:

[1] Arnoux JB,Verkarre V,Samt-Martm C,et al.Congenital hyperin-sulinism:current trends in diagnosis and therapy[J].Orphanet J Rare Dis,2011,6:63.
[2] Arnoux JB,de Lonlay P,Ribeiro MJ,et al.Congenital hyperin-sulinism[J].Early Hum Dev,2010,86(5):287-294.
[3] Bellanné-Chantelot C,Saint-Martin C,Ribeiro M J,et al.ABCC8 and KCNJ11 molecular spectrum of 109 patients with diazoxide-unresponsive congenital hyperinsulinism[J].J Med Genet,2010,47(11):752-759.
[4] Ismail D,Hussain K.Role of 18F-DOPA PET/CT imaging in con-genital hyperinsulinism[J].Rev Endocr Metab Disord,2010,11(3):165-169.
[5] Hussain K,Sepp?nen M,N?nto-Sal?nen K,et al.The diagnosis ofectopic focal hyperinsulinism of infancy with[18F]-dopa positronemission tomography[J].J Clin Endocrinol Metab,2006,91(8):2839-2842.
[6] Peranteau W H,Bathaii SM,Pawel B,et al.Multiple ectopic lesions of focal islet adenomatosis identified by positron emission tomogra-hy scan in an infant with congenital hyperinsulinism[J].J Pediatr Surg,2007,42(1): 188-192.
[7] Otonkoski T,N?nt?-Salonen K,Sepp?nen M,et al.Noninvasive di-gnosis of focal hyperinsulinism of infancy with[18F]-DOPA positron emission tomography[J].Diabetes,2006,55(1): 13-18.
[8] de Lonlay P,Simon-Carre A,Ribeiro M J,et al.Congenital hyper-nsulinism: pancreatic[18F]fluoro-L-dihydroxyphenylalanine(DOPA) positron emission tomography and immunohistochemistry study of DOPA decarboxylase and insulin secretion[J].J Clin Endocrinol Metab,2006,91(3): 933-940.
[9] Meintjes M,Endozo R,Dickson J,et al.18F-DOPA PET and en-anced CT imaging for congenital hyperinsulinism: initial UK ex-erience from a technologist’s perspective[J].Nucl Med Commun,2013,34(6):601-608.
[10] Koopmans KP,Neels ON,Kema IP,et al.Molecular imaging in neuroendocrine tumors: molecular uptake mechanisms and clinical results[J].Crit Rev Oncol Hematol,2009,71(3): 199-213.
[11] Jager PL,Chirakal R,Marriott CJ,et al.6-L-18F-fluorodihydrox-yphenylalanine PET in neuroendocrine tumors: basic aspects and emerging clinical applications[J].J Nucl Med,2008,49(4): 573-586.
[12] Ribeiro MJ,De Lonlay P,Delzescaux T,et al.Characterization of hyperinsulinism in infancy assessed with PET and 18F-fluoro-L-DOPA[J].J Nucl Med,2005,46(4): 560-566.
[13] Mohnike K,Blankenstein O,Minn H,et al.[18F]-DOPA positron emission tomography for preoperative localization in congenital hyperinsulinism[J].Horm Res,2008,70(2): 65-72.
[14] Hardy OT,Hernandez-Pampaloni M,Saffer JR,et al.Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and lo璫alizing focal congenital hyperinsulinism[J].J Clin Endocrinol Metab,2007,92(12): 4706-4711.
[15] Laje P,States LJ,Zhuang H,et al.Accuracy of PET/CT Scan in the diagnosis of the focal form of congenital hyperinsulinism[J].J Pedi-atr Surg,2013,48(2): 388-393.
[16] Capito C,Khen-Dunlop N,Ribeiro MJ,et al.Value of 18F-fluoro-L-dopa PET in the preoperative localization of focal lesions in con-enital hyperinsulinism[J].Radiology,2009,253(1): 216-222.
[17] Zani A,Nah SA,Ron O,et al.The predictive value of preoperative fluorine-18-L-3,4-dihydroxyphenylalanine positron emission to-ography-computed tomography scans in children with congenital hyperinsulinism of infancy[J].J Pediatr Surg,2011,46(1): 204-208.
[18] Masue M,Nishibori H,Fukuyama S,et al.Diagnostic accuracy of [18F]-fluoro-L-dihydroxyphenylalanine positron emission tomogra-hy scan for persistent congenital hyperinsulinism in Japan[J].Clin Endocrinol(Oxf),2011,75(3): 342-346.
[19] Yang J,Hao R,Zhu X.Diagnostic role of 18F-dihydroxyphenylala-nine positron emission tomography in patients with congenital hy-perinsulinism: a meta-analysis[J].Nucl Med Commun,2013,34(4): 347-353.
[20] Yang J,Yuan L,Meeks J K,et al.18F-DOPA positron emission to mography/computed tomography application in congenital hyperin-sulinism[J].J Pediatr Endocrinol Metab,2012,25(7-8): 619-622.

备注/Memo

备注/Memo:
收稿日期:2014-11-12。
基金项目:国家自然科学基金(81101069);2012年北京市卫生系统"十百千"卫生人才"百"层次人选(2013-3-066)
通讯作者:杨吉刚,Email:nmyangjigang@gmail.com
更新日期/Last Update: 1900-01-01